92 related articles for article (PubMed ID: 22579635)
1. A novel role for phospholipase D as an endogenous negative regulator of platelet sensitivity.
Elvers M; Grenegård M; Khoshjabinzadeh H; Münzer P; Borst O; Tian H; Di Paolo G; Lang F; Gawaz M; Lindahl TL; Fälker K
Cell Signal; 2012 Sep; 24(9):1743-52. PubMed ID: 22579635
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report.
Stegner D; Thielmann I; Kraft P; Frohman MA; Stoll G; Nieswandt B
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2212-7. PubMed ID: 23868933
[TBL] [Abstract][Full Text] [Related]
3. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis.
Su W; Yeku O; Olepu S; Genna A; Park JS; Ren H; Du G; Gelb MH; Morris AJ; Frohman MA
Mol Pharmacol; 2009 Mar; 75(3):437-46. PubMed ID: 19064628
[TBL] [Abstract][Full Text] [Related]
5. Novel lipid-soluble thiol-redox antioxidant and heavy metal chelator, N,N'-bis(2-mercaptoethyl)isophthalamide (NBMI) and phospholipase D-specific inhibitor, 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) attenuate mercury-induced lipid signaling leading to protection against cytotoxicity in aortic endothelial cells.
Secor JD; Kotha SR; Gurney TO; Patel RB; Kefauver NR; Gupta N; Morris AJ; Haley BE; Parinandi NL
Int J Toxicol; 2011 Dec; 30(6):619-38. PubMed ID: 21994240
[TBL] [Abstract][Full Text] [Related]
6. Signaling mechanisms of inhibition of phospholipase D activation by CHS-111 in formyl peptide-stimulated neutrophils.
Chang LC; Huang TH; Chang CS; Tsai YR; Lin RH; Lee PW; Hsu MF; Huang LJ; Wang JP
Biochem Pharmacol; 2011 Jan; 81(2):269-78. PubMed ID: 20965153
[TBL] [Abstract][Full Text] [Related]
7. CLP36 is a negative regulator of glycoprotein VI signaling in platelets.
Gupta S; Braun A; Morowski M; Premsler T; Bender M; Nagy Z; Sickmann A; Hermanns HM; Bösl M; Nieswandt B
Circ Res; 2012 Nov; 111(11):1410-20. PubMed ID: 22955732
[TBL] [Abstract][Full Text] [Related]
8. Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.
Ganesan R; Mahankali M; Alter G; Gomez-Cambronero J
Biochim Biophys Acta; 2015 Mar; 1851(3):261-72. PubMed ID: 25532944
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary fibrosis inducer, bleomycin, causes redox-sensitive activation of phospholipase D and cytotoxicity through formation of bioactive lipid signal mediator, phosphatidic acid, in lung microvascular endothelial cells.
Patel RB; Kotha SR; Sherwani SI; Sliman SM; Gurney TO; Loar B; Butler SO; Morris AJ; Marsh CB; Parinandi NL
Int J Toxicol; 2011 Feb; 30(1):69-90. PubMed ID: 21131602
[TBL] [Abstract][Full Text] [Related]
10. Reversible bleb formation in mast cells stimulated with antigen is Ca2+/calmodulin-dependent and bleb size is regulated by ARF6.
Yanase Y; Carvou N; Frohman MA; Cockcroft S
Biochem J; 2009 Dec; 425(1):179-93. PubMed ID: 19845506
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase D in platelets and other cells.
Vorland M; Thorsen VA; Holmsen H
Platelets; 2008 Dec; 19(8):582-94. PubMed ID: 19012176
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase D-mediated hydrolysis of phosphatidylcholine: role in cell signalling.
Liscovitch M; Ben-Av P; Danin M; Faiman G; Eldar H; Livneh E
J Lipid Mediat; 1993 Nov; 8(3):177-82. PubMed ID: 8268464
[TBL] [Abstract][Full Text] [Related]
13. Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1.
Elvers M; Stegner D; Hagedorn I; Kleinschnitz C; Braun A; Kuijpers ME; Boesl M; Chen Q; Heemskerk JW; Stoll G; Frohman MA; Nieswandt B
Sci Signal; 2010 Jan; 3(103):ra1. PubMed ID: 20051593
[TBL] [Abstract][Full Text] [Related]
14. Regulation of phospholipase D activity and phosphatidic acid production after purinergic (P2Y6) receptor stimulation.
Scott SA; Xiang Y; Mathews TP; Cho HP; Myers DS; Armstrong MD; Tallman KA; O'Reilly MC; Lindsley CW; Brown HA
J Biol Chem; 2013 Jul; 288(28):20477-87. PubMed ID: 23723068
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase D activity in human platelets is inhibited by protein kinase A, involving inhibition of phospholipase D1 translocation.
Vorland M; Holmsen H
Platelets; 2008 Jun; 19(4):300-7. PubMed ID: 18569866
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor stimulates phosphatidic acid formation in cultured rat mesangial cells: roles of phospholipase D, diglyceride kinase, and de novo phospholipid synthesis.
Kester M
J Cell Physiol; 1993 Aug; 156(2):317-25. PubMed ID: 8393878
[TBL] [Abstract][Full Text] [Related]
17. An indirect pathway of receptor-mediated 1,2-diacylglycerol formation in mast cells. I. IgE receptor-mediated activation of phospholipase D.
Gruchalla RS; Dinh TT; Kennerly DA
J Immunol; 1990 Mar; 144(6):2334-42. PubMed ID: 2138197
[TBL] [Abstract][Full Text] [Related]
18. Redundant functions of phospholipases D1 and D2 in platelet α-granule release.
Thielmann I; Stegner D; Kraft P; Hagedorn I; Krohne G; Kleinschnitz C; Stoll G; Nieswandt B
J Thromb Haemost; 2012 Nov; 10(11):2361-72. PubMed ID: 22974101
[TBL] [Abstract][Full Text] [Related]
19. Agonist-mediated activation of phosphatidylcholine-specific phospholipase C and D in intestinal smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1995 Aug; 48(2):293-304. PubMed ID: 7651363
[TBL] [Abstract][Full Text] [Related]
20. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
